ICL Israel Chemicals Ltd Total Liabilities
ICL Israel Chemicals Ltd total liabilities. Based on the latest financial reports, ICL Israel Chemicals Ltd (ICL) has total liabilities worth ILA6.75 Billion ILA (≈ $18.08 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ICL Israel Chemicals Ltd (ICL) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of ICL Israel Chemicals Ltd (2000–2025)
Total liabilities of ICL Israel Chemicals Ltd from 2000 to 2025. This chart illustrates how ICL Israel Chemicals Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore ICL strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
ICL Israel Chemicals Ltd Competitors by Total Liabilities
The table below lists competitors of ICL Israel Chemicals Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ollie's Bargain Outlet Hldg
NASDAQ:OLLI
|
USA | $1.10 Billion |
|
Arkema SA
PA:AKE
|
France | €7.88 Billion |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
USA | $1.14 Billion |
|
Sonoco Products Company
NYSE:SON
|
USA | $7.48 Billion |
|
Macy’s Inc
NYSE:M
|
USA | $11.38 Billion |
|
One Gas Inc
NYSE:OGS
|
USA | $5.30 Billion |
|
White Mountains Insurance Group Ltd
NYSE:WTM
|
USA | $5.81 Billion |
|
Symbotic Inc
NASDAQ:SYM
|
USA | $2.39 Billion |
Liability Composition Analysis (2000–2025)
This chart breaks down ICL Israel Chemicals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of ICL Israel Chemicals Ltd.
Liquidity & Leverage Metrics
ICL Israel Chemicals Ltd Total Liabilities Ratios Explained
ICL Israel Chemicals Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.58 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ICL Israel Chemicals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ICL Israel Chemicals Ltd (2000–2025)
The table below shows the annual total liabilities of ICL Israel Chemicals Ltd from 2000 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ILA6.17 Billion ≈ $16.54 Million |
+15.67% |
| 2024-12-31 | ILA5.33 Billion ≈ $14.30 Million |
-4.58% |
| 2023-12-31 | ILA5.59 Billion ≈ $14.99 Million |
-7.40% |
| 2022-12-31 | ILA6.04 Billion ≈ $16.18 Million |
-4.84% |
| 2021-12-31 | ILA6.34 Billion ≈ $17.01 Million |
+13.77% |
| 2020-12-31 | ILA5.58 Billion ≈ $14.95 Million |
+9.08% |
| 2019-12-31 | ILA5.11 Billion ≈ $13.71 Million |
+5.75% |
| 2018-12-31 | ILA4.83 Billion ≈ $12.96 Million |
-16.42% |
| 2017-12-31 | ILA5.78 Billion ≈ $15.51 Million |
-1.85% |
| 2016-12-31 | ILA5.89 Billion ≈ $15.80 Million |
+0.07% |
| 2015-12-31 | ILA5.89 Billion ≈ $15.79 Million |
+10.13% |
| 2014-12-31 | ILA5.35 Billion ≈ $14.34 Million |
+24.51% |
| 2013-12-31 | ILA4.29 Billion ≈ $11.51 Million |
-1.20% |
| 2012-12-31 | ILA4.35 Billion ≈ $11.65 Million |
+4.03% |
| 2011-12-31 | ILA4.18 Billion ≈ $11.20 Million |
+11.51% |
| 2010-12-31 | ILA3.75 Billion ≈ $10.05 Million |
+20.37% |
| 2009-12-31 | ILA3.11 Billion ≈ $8.35 Million |
-3.54% |
| 2008-12-31 | ILA3.23 Billion ≈ $8.65 Million |
+16.40% |
| 2007-12-31 | ILA2.77 Billion ≈ $7.43 Million |
+48.06% |
| 2006-12-31 | ILA1.87 Billion ≈ $5.02 Million |
+2.68% |
| 2005-12-31 | ILA1.82 Billion ≈ $4.89 Million |
-0.78% |
| 2004-12-31 | ILA1.84 Billion ≈ $4.93 Million |
-9.70% |
| 2003-12-31 | ILA2.04 Billion ≈ $5.46 Million |
-3.94% |
| 2002-12-31 | ILA2.12 Billion ≈ $5.68 Million |
+0.08% |
| 2001-12-31 | ILA2.12 Billion ≈ $5.68 Million |
-10.92% |
| 2000-12-31 | ILA2.38 Billion ≈ $6.37 Million |
-- |
About ICL Israel Chemicals Ltd
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. The company operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Growing Solutions. The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; sells various gr… Read more